复方醒脑液治疗颅脑损伤后综合征的临床观察

目的 观察复方醒脑液治疗颅脑损伤后综合征（PTBS）的疗效。方法 2011~2015年收治PTBS 80例，其中40例给予西医常规治疗（对照组），40例在对照组基础上口服复方醒脑液（观察组；每次50 ml，每日2次）。采用临床疗效及90项症状清单（SCL-90）评分评估复方醒脑液治疗PTBS的效果。结果 观察组临床治愈2例，显效15例，好转10例，无效13例；对照组显效4例，好转10例，无效26例；观察组总有效率（67.5%，27/40）明显高于对照组（35.0%，14/40；P<0.05）。治疗后，观察组scl-90总分、躯体化评分、人际关系敏感评分较治疗前均明显降低（>P<0.05）；而且，明显低于对照组治疗后的评分（>P<0.05）。>结论 复方醒脑液具有减轻PTBS头痛、眩晕等症候群的作用；用药后躯体症状、人际关系敏感改善明显，对睡眠、饮食也有所改善。

Clinical observation on treatment of compound decoction for cerebral prorection for post-traumatic brain syndrome

Objective To observe the curative effect of compound decoction for cerebral prorection (CDCP) on post-traumatic brain syndrome. Methods The clinical data of 80 patients with post-traumatic brain syndrome, of whom, 40 received conventional treatment (control group) and 40 received CDCP expect the conventional treatment (observed group). The symptom cheklist 90 (SCL-90) score was used to assessed curative effect. Results The effective rate [67.5%(27/40)] was significantly higher in observed group than that [35.0% (14/40)] in control group (P<0.01). the="" total="" score="" [(170.21±21.62)="" points],="" body="" [(2.06±0.41)="" interpersonal="" sensitivity="" [(2.03±0.24)="" points]="" of="" scl-90="" were="" significantly="" lower="" in="" observed="" group="" than="" those="" [(187.51±28.54)="" points,="" (2.39±0.31)="" (2.36±0.34)="" respectively]="" control="" (P